Evaluation of therapeutic drug monitoring of antiepileptic drugs

International Journal of Clinical Pharmacology and Therapeutics

Volumn 41, Issue 3, 2003, Pages 126-131

  Irshaid, Y M ^a   Hamdi, A A ^a   Al Homrany, M ^b  

^a KING KHALID UNIVERSITY   (Saudi Arabia)

^b KING KHALID UNIVERSITY   (Saudi Arabia)

Author keywords

Carbamazepine; Phenobarbital; Phenytoin; Therapeutic drug monitoring; Valporic acid

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; EPILEPSY; FEMALE; HUMAN; IMMUNOASSAY; INFANT; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRESCRIPTION; SAUDI ARABIA; STATISTICAL ANALYSIS; TEACHING HOSPITAL;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG MONITORING; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HOSPITALS, TEACHING; HUMANS; INFANT; MALE; MIDDLE AGED; PHENOBARBITAL; PHENYTOIN; POLYPHARMACY; VALPROIC ACID;

EID: 0037343713     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Brodie MJ, Dichter MA 1996 Drug therapy: antiepileptic drugs. N Engl J Med 334: 168-175
2. Chadwick D 1994 Standard approach to antiepileptic drug treatment in the United Kingdom. Epilepsia 35 (Suppl 4): S3-S10
3. Evans WE, Schentag JJ, Jusko WJ 1992 Applied pharmacokinetics: principles of therapeutic drug monitoring. Applied Therapeutics, Inc. Vancouver, WA
4. Ferrendelli JA 1999 Pharmacology of antiepileptic drug polypharmacy. Epilepsia 40 (Suppl 5): S81-S83.
5. Fröscher W, Kramer G, Schmidt D, Stefan H 1999 Serum concentration of anticonvulsants. Practical guidelines for measuring and useful interpretation. Therapy Committee of the German Section of the International Epilepsy League. Nervenarzt 70: 172-177
6. Jannuzzi G, Cian P, Fattore C, Gatti G, Bartoli A, Monaco F, Perucca E 2000 A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group in Epilepsy. Epilepsia 41: 222-230
7. Liu H, Delgado MR 1994 Improved therapeutic monitoring of drug interactions in epileptic children using carbamazepine polytherapy. Ther Drug Monit 16: 132-138
8. Lott RS, McAuley JW 2001 Seizure Disorders. In: Koda-Kimble MA, Young LY (eds) Applied therapeutics, the clinical use of drugs. Lippincott Williams and Wilkins, Baltimore, pp 1-52
9. Patsalos PN, Fröscher W, Pisani F, van Rijn CM 2002 The importance of drug interactions in epilepsy therapy. Epilepsia 43: 365-385
10. Pellock JM 1994 Standard approach to antiepileptic drug treatment in the United States. Epilepsia 35 (Suppl 4): S11-S18
11. Perucca E, Dulac O, Shorvon S, Tomson T 2001 Harnessing the clinical potential of antiepileptic drug therapy: dosage optimization. CNS Drugs 15: 609-621
12. Rochat P, Hallas J, Gaist D, Friis ML 2001 Antiepileptic drug utilization: a Danish prescription database analysis. Acta Neurol Scand 104: 6-11
13. Yukawa E 1996 Optimization of antiepileptic drug therapy. The importance of serum drug concentration monitoring. Clin Pharmacokinet 31: 120-130